Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Viking Therapeutics Inc VKTX

Healthcare Biotechnology
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders, which is being evaluated in a Phase II b... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VKTX)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

PR Newswire 4 hours ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Accesswire 3 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Accesswire 5 days ago

VKTX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Viking Therapeutics, Inc.

Accesswire 5 days ago

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

PR Newswire 6 days ago

Did Viking Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - VKTX

Accesswire 7 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

PR Newswire 7 days ago

Levi & Korsinsky Reminds Shareholders of an Investigation into Viking Therapeutics, Inc. (VKTX) Regarding Potential Securities Fraud Allegations

Accesswire 7 days ago

ATTENTION VKTX SHAREHOLDERS: Investors who lost money on Viking Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

Accesswire 9 days ago
View More News ››

Opinion & Analysis (NDAQ:VKTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VKTX)

Is Viking Therapeutics a Millionaire-Maker?

Breaking News: $VKTX Is Viking Therapeutics a Millionaire-Maker?2024-07-19 05:50:00 ET Fortunes have been made on biotech stocks over...
whytestocks - July 19, 2024

VKTX Price Target Alert: $105.00. Issued by Morgan Stanley

NEWS: $VKTX VKTX Price Target Alert: $105.00. Issued by Morgan Stanley2024-06-27 06:00:08 ET Michael Ulz from Morgan Stanley issued a...
whytestocks - June 27, 2024

2 Growth Stocks Wall Street Analysts Think Can Soar by at Le

JUST IN: $VKTX 2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%2024-06-15 09:31:00 ET The S@P 500 remains near record...
whytestocks - June 15, 2024

Viking Therapeutics Is Great. Here's Why You Shouldn't Buy I

News; $VKTX Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.2024-04-08 05:55:00 ET Viking Therapeutics (NASDAQ...
whytestocks - April 8, 2024

Why Viking Therapeutics Stock Is Plunging Today

Breaking News: $VKTX Why Viking Therapeutics Stock Is Plunging Today2024-03-07 12:05:53 ET Shares of Viking Therapeutics (NASDAQ: VKTX...
whytestocks - March 7, 2024

Viking's new weight-loss drug shows early potential

https://stockhouse.com/news/the-market-online-news/2024/02/28/viking-therapeutics-new-weight-loss-drug-shows-early-potential
TrevorAbes - February 28, 2024
View more Bullboard ››

Benton Resources Inc.

Benton Resources Inc.

Benton Resources Inc. is a mineral exploration company listed on the TSX Venture Exchange under the symbol BEX. Benton has a ...
View More »